• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A hyperkeratotic drug reaction in a patient on antiretroviral therapy.

作者信息

Felix Kayla H, Sangueza Omar, Feldman Steven R, Mariencheck Maria

机构信息

Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina.

出版信息

JAAD Case Rep. 2020 Oct 12;6(12):1239-1241. doi: 10.1016/j.jdcr.2020.10.001. eCollection 2020 Dec.

DOI:10.1016/j.jdcr.2020.10.001
PMID:33294553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7701028/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e1d/7701028/b52442fe2e29/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e1d/7701028/c4d18e38a583/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e1d/7701028/b52442fe2e29/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e1d/7701028/c4d18e38a583/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e1d/7701028/b52442fe2e29/gr2.jpg

相似文献

1
A hyperkeratotic drug reaction in a patient on antiretroviral therapy.一名接受抗逆转录病毒治疗的患者发生了角化过度性药物反应。
JAAD Case Rep. 2020 Oct 12;6(12):1239-1241. doi: 10.1016/j.jdcr.2020.10.001. eCollection 2020 Dec.
2
3
Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide.在初始使用比克替拉韦、恩曲他滨/丙酚替诺福韦或多替拉韦/恩曲他滨/丙酚替诺福韦治疗后，换用比克替拉韦/恩曲他滨/丙酚替诺福韦复方制剂。
AIDS. 2018 Jul 31;32(12):1723-1725. doi: 10.1097/QAD.0000000000001894.
4
Effects of antiretroviral combination therapies F/TAF, E/C/F/TAF and R/F/TAF on insulin resistance in healthy volunteers: the TAF-IR Study.抗逆转录病毒联合疗法F/TAF、E/C/F/TAF和R/F/TAF对健康志愿者胰岛素抵抗的影响：TAF-IR研究
Antivir Ther. 2018;23(7):629-632. doi: 10.3851/IMP3271. Epub 2018 Oct 3.
5
Infrequent development of drug resistance in HIV-1-infected treatment-naive subjects after 96 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate.在初治的HIV-1感染受试者中，使用埃替格韦/考比司他/恩曲他滨/替诺福韦艾拉酚胺或埃替格韦/考比司他/恩曲他滨/替诺福韦酯进行96周治疗后耐药性出现频率较低。
Antivir Ther. 2017;22(5):443-446. doi: 10.3851/IMP3125. Epub 2017 Jan 11.
6
Short-term Adverse Events With BIC/FTC/TAF: Postmarketing Study.BIC/FTC/TAF的短期不良事件：上市后研究。
Open Forum Infect Dis. 2020 Sep 3;7(9):ofaa285. doi: 10.1093/ofid/ofaa285. eCollection 2020 Sep.
7
Profile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date.比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺固定剂量复方制剂概况及其在治疗HIV-1感染中的潜力：迄今的证据
HIV AIDS (Auckl). 2018 Oct 29;10:203-213. doi: 10.2147/HIV.S145529. eCollection 2018.
8
Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission.纳米封装为替诺福韦艾拉酚胺和恩曲他滨药物组合带来长效现象：针对 HIV-1 阴道传播的预防效果比较研究。
J Control Release. 2019 Jan 28;294:216-225. doi: 10.1016/j.jconrel.2018.12.027. Epub 2018 Dec 18.
9
Fixed dose darunavir boosted with cobicistat combined with emtricitabine and tenofovir alafenamide fumarate.固定剂量达芦那韦/考比司他与恩曲他滨/替诺福韦艾拉酚胺富马酸盐复方制剂。
Curr Opin HIV AIDS. 2018 Jul;13(4):315-319. doi: 10.1097/COH.0000000000000465.
10
Rare emergence of drug resistance in HIV-1 treatment-naïve patients receiving elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide for 144 weeks.在接受艾维雷韦/考比司他/恩曲他滨/替诺福韦艾拉酚胺治疗 144 周的 HIV-1 初治患者中罕见出现耐药性。
J Clin Virol. 2018 Jun;103:37-42. doi: 10.1016/j.jcv.2018.03.012. Epub 2018 Apr 2.

本文引用的文献

1
HIV-associated psoriasis: Epidemiology, pathogenesis, and management.HIV 相关性银屑病：流行病学、发病机制与治疗。
Dermatol Ther. 2019 Mar;32(2):e12806. doi: 10.1111/dth.12806. Epub 2019 Jan 6.
2
Profile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date.比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺固定剂量复方制剂概况及其在治疗HIV-1感染中的潜力：迄今的证据
HIV AIDS (Auckl). 2018 Oct 29;10:203-213. doi: 10.2147/HIV.S145529. eCollection 2018.
3
Skin Diseases in the Era of Highly Active Antiretroviral Therapy: A Retrospective Study of 534 Patients.
高效抗逆转录病毒治疗时代的皮肤疾病：对534例患者的回顾性研究
J Int Assoc Provid AIDS Care. 2018 Jan-Dec;17:2325957417752255. doi: 10.1177/2325957417752255.
4
A case of secondary syphilis mimicking palmoplantar psoriasis in HIV infected patient.1例HIV感染患者中表现为掌跖银屑病的二期梅毒病例。
An Bras Dermatol. 2015 May-Jun;90(3 Suppl 1):216-9. doi: 10.1590/abd1806-4841.20153399.
5
Investigation of emtricitabine-associated skin pigmentation and safety in HIV-1-infected Japanese patients.研究恩曲他滨相关的皮肤色素沉着和安全性在 HIV-1 感染的日本患者。
J Infect Chemother. 2011 Oct;17(5):602-8. doi: 10.1007/s10156-011-0222-5. Epub 2011 Mar 3.
6
Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection.人类免疫缺陷病毒感染患者中与最新抗逆转录病毒药物相关的皮肤不良反应。
J Antimicrob Chemother. 2008 Nov;62(5):879-88. doi: 10.1093/jac/dkn292. Epub 2008 Jul 23.
7
Adverse effects of antiretroviral therapy.抗逆转录病毒疗法的不良反应。
Lancet. 2000 Oct 21;356(9239):1423-30. doi: 10.1016/S0140-6736(00)02854-3.
8
Primary and secondary syphilis: a histopathological study.一期和二期梅毒：一项组织病理学研究。
Int J STD AIDS. 1991 Jul-Aug;2(4):280-4. doi: 10.1177/095646249100200411.
9
Keratodermia blennorrhagica and mucocutaneous manifestations of Reiter's syndrome.淋病性角化病与赖特综合征的皮肤黏膜表现
Ann Rheum Dis. 1979;38 Suppl 1(Suppl 1):suppl 68-72. doi: 10.1136/ard.38.suppl_1.68.